What do you think of the Terminator fixing cancer? While perhaps not as radical, Quantum International (PINK: QUAN) is looking at using nanobots—very, very tiny creations—to attack cancer. And it’s pretty promising.
At the NanoRobotics Lab in Canada’s École Polytechnique de Montréal, scientists have successfully steered tiny robots wirelessly through blood vessels of living organisms with the aid of magnetic coils found in MRI machines. These microscopic robots can easily access places within the body that catheters cannot, and they can execute incredibly precise maneuvers that would otherwise require invasive surgery.
From the Daily Finance:
"Using robots to deliver cancer-killing medicine directly to a tumor deep within the body could forever change the treatment of the disease," said Quantum CEO Robert Federowicz. "The market for such astonishing technology would obviously be enormous. Quantum is dedicated to bringing just such innovations out of the laboratory and into the global marketplace."
Quantum is leading the pack for bringing powerful new medical technologies to the market. The company is, at present, close to clinching a deal with the Polish Industrial Research Institute for Automation and Measurement to commercialize the Resuscitator – a portable device that could help ensure chest compressions are administered perfectly. Compressions, the most vital part of CPR, are also the most prone to human error, and broken ribs are not uncommon.
The next generation of robotics in medical science will be populated by names like Quantum, iRobot (NASDAQ: IRBT), Dover (NYSE: DOV), and Intuitive Surgical (NASDAQ: ISRG).
